Cross-Resistance of an Amsacrine-Resistant Human Leukemia Line to Topoisomerase II Reactive DNA Intercalating Agents. Evidence for Two Topoisomerase II Directed Drug Actions
1991
HL-60/AMSA is a human leukemia cell line that is 50−100-fold more resistant than its drug-sensitive HL-60 parent line to the cytotoxic actions of the DNA intercalator amsacrine (m-AMSA). HL-60/AMSA topoisomerase II is also resistant to the inhibitory actions of m-AMSA. HL-60/AMSA cells and topoisomerase II are cross-resistant to anthracycline and ellipticine intercalators but relatively sensitive to the nonintercalating topoisomerase II reactive epipodophyllοtoxin etoposide. We now demonstrate that HL-60/AMSA and its topoisomerase II are cross-resistant to the DNA intercalators mitoxantrone and amonafide, thus strongly indicating that HL-60/AMSA and its topoisomerase II are resistant to topoisomerase II reactive intercalators but not to nonintercalators
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
48
References
38
Citations
NaN
KQI